Role of soluble urokinase plasminogen activator receptor in critically ill children with hospital-acquired pneumonia: an observational study in hospital with controls.
Nagwan Yossery SalehShimaa Elshafy SolimanMohammed Adel AboukouraMohamed Ibrahim GaribPublished in: BMJ paediatrics open (2024)
suPAR can be used as a predictor for severity of illness in children with HAP. We firmly know that plasma suPAR, a novel marker, could indicate the disease if carried out on larger patient groups.